Submit Deal

PARAGON BIOSCIENCES

Summary

Paragon Biosciences is a life science innovator, accelerating the development of revolutionary technologies, new medicines and breakthrough treatments.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 285 M

Avg. Deal Size£ 142 M

Market Context

Senior Management

Jeff Aronin
Founder, Chairman and Chief Executive Officer
Sheridan Chaney
Director Corporate Communications

Sort

10 Jan 2022|United States|Health Care Services

Target: NOVAVITA THERA

Bidder: CASTLE CREEK BIOSCIENCES

4 Service Providers

4 Bidder

7 Dealmakers

7 Bidder

n/a

Value

03 Nov 2022|United States|Pharmaceuticals

Target: EMALEX BIOSCIENCES

Bidder: BAIN CAPITAL LIFE SCIENCES

5 Service Providers

1 Target | 4 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 217 M

Value

27 Sep 2023|United States|Biotechnology

Target: EVOZYNE

Bidder: FIDELITY MANAGEMENT & RESEARCH COMPANY

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 66 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy